Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
Cases of community-acquired Pseudomonas aeruginosa bacteraemia (n = 39) that occurred at a tertiary-care hospital during a 5-year period were analysed retrospectively. The commonest underlying diseases were solid tumour (41%) and haematological malignancy (18%). Most (44%) of the patients were neutropenic, and 39% had septic shock at initial presentation. The 30-day attributable mortality rate was 39%. Two previously healthy patients were identified with fatal P. aeruginosa pneumonia with bacteraemia. P. aeruginosa bacteraemia is a fatal infection that should be considered in the differential diagnosis of patients presenting from the community with rapidly progressive sepsis.
Kang
C-I
CI
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kim
S-H
SH
Park
W B
WB
Lee
K-D
KD
Kim
H-B
HB
Kim
E-C
EC
Oh
M-D
MD
Choe
K-W
KW
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D015897:Comorbidity; D005260:Female; D019337:Hematologic Neoplasms / Q000473:pathology; D006761:Hospitals; D006801:Humans; D007723:Korea / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000473:pathology; D009503:Neutropenia / Q000453:epidemiology / Q000473:pathology; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D011550:Pseudomonas aeruginosa; D012189:Retrospective Studies; D012307:Risk Factors; D012772:Shock, Septic / Q000473:pathology
D000900:Anti-Bacterial Agents